Sdiptech Q2: Sales and EBITA 5% Above Expectations - Redeye

Redeye retains its positive view on Sdiptech following a Q2 report beating our forecasts by 5%, mainly due to strong performance in recently acquired businesses. Organic growth was negative as temporary issues are hurting a few units. Also, some units have not yet fully passed on cost increases. Thus, we believe organic growth will pick up. We will likely leave our forecasts and Base Case largely unchanged.

Länk till analysen i sin helhet: https://www.redeye.se/research/849139/sdiptech-q222-sales-and-ebita-5-above-expectations?utm_source=finwire&utm_medium=RSS